| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $22.88M | - | |
| Other | 138.6K | $7.33M | - | |
| Other | 123.1K | $6.51M | - | |
| CFO | 116.9K | $6.18M | - | |
| Other | 111.5K | $5.89M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 | Dube Eric M57 | Chief Executive Officer | Sell | 17,332 | $30.08 | $521,406.72 | -3.8% | -3.3% | -30.0% | |
| Nov 16, 2021 | Aselage Steve80 | Director | Sell | 31,800 | $29.39 | $934,602.00 | -17.5% | -5.0% | -28.2% | |
| Nov 5, 2021 | Aselage Steve80 | Director | Sale+OE | 10,000 | $26.23 | $262,300.00 | -5.8% | -13.7% | -31.0% | |
| Nov 2, 2021 | Aselage Steve80 | Director | Sell | 8,500 | $29.69 | $252,400.00 | -16.7% | -8.8% | -29.1% | |
| Oct 7, 2021 | Aselage Steve80 | Director | Sale+OE | 60,000 | $26.25 | $1,574,760.00 | -12.7% | +12.6% | -5.1% | |
| Oct 4, 2021 | Heerma Peter53 | Chief Commercial Officer | Sell | 3,058 | $24.77 | $75,746.05 | -4.8% | +22.7% | +4.3% | |
| Aug 17, 2021 | Clague Laura64 | Chief Financial Officer | Sell | 1,407 | $17.12 | $24,085.31 | -4.3% | +48.9% | +40.8% | |
| Aug 17, 2021 | Heerma Peter53 | Chief Commercial Officer | Sell | 1,407 | $17.12 | $24,086.01 | -2.2% | +48.9% | +40.8% | |
| Aug 17, 2021 | Dube Eric M57 | Chief Executive Officer | Sell | 7,836 | $17.12 | $134,142.13 | -4.8% | +48.9% | +40.8% | |
| Aug 17, 2021 | Rosenberg Noah L. | Chief Medical Officer | Sell | 1,407 | $17.12 | $24,085.03 | -2.9% | +48.9% | +40.8% |